Monthly Archives: October 2015

[Source: Picower Institute for Learning and Memory, October 16, 2015] Taking advantage of genetic heterogeneity in autism and other neurodevelopmental disorders could lead to precision therapies. Genetic research suggests that hundreds of genes are likely risk factors for neurodevelopmental disorders such as autism. This heterogeneity presents both challenges and opportunities when it […]

Leveraging genetic diversity to drive precision medicine

[Source: AutismSpeaks.org, October 15, 2015]   Today in Science magazine, Harvard neurologist Mustafa Sahin and MIT brain scientist Mriganka Sur summarize scientific progress toward delivering precision treatments for autism spectrum disorder (ASD). “Given the large number of genes that potentially confer ASD risk, the genetic heterogeneity of ASD presents a substantial obstacle to development […]

Sur and Sahin propose that biomarkers are crucial for future ...